Skip to main content
Erschienen in: Journal of Neurology 3/2012

01.03.2012 | Original Communication

The pattern of cortical atrophy in Parkinson’s disease with mild cognitive impairment according to the timing of cognitive dysfunction

verfasst von: Ji E. Lee, Kyoo H. Cho, Myonghwan Kim, Young H. Sohn, Phil Hyu Lee

Erschienen in: Journal of Neurology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The density of Lewy bodies or the concurrent β-amyloid pathology would act as modulators in the relative timing of dementia during the course of Parkinson’s disease. Depending on the temporal relationship between the onset of parkinsonism and that of cognitive impairment, patients with Parkinson’s disease with mild cognitive impairment were divided into two groups of earlier (<1 year) and later (≥1 year) cognitive decline, and cortical atrophy patterns and correlation of gray matter and timing of cognitive decline were analyzed using voxel-based morphometry. The morphometric analysis showed that patients with earlier cognitive decline demonstrated greater cortical atrophy in the inferior parietal and orbitofrontal areas than did those with later cognitive decline. Additionally, the anatomical bases of the timing of their cognitive decline differed in terms of correlation patterns. These data suggest that the pathological burden in Parkinson’s disease with mild cognitive impairment may be more severe in patients with earlier cognitive decline than in those with later cognitive decline, and that the neural basis corresponding to the timing of cognitive decline may differ in these patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hurtig HI, Trojanowski JQ, Galvin J et al (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology 54:1916–1921PubMed Hurtig HI, Trojanowski JQ, Galvin J et al (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology 54:1916–1921PubMed
2.
Zurück zum Zitat Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005) Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol 58:773–776PubMedCrossRef Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005) Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol 58:773–776PubMedCrossRef
3.
Zurück zum Zitat Ballard C, Ziabreva I, Perry R et al (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67:1931–1934PubMedCrossRef Ballard C, Ziabreva I, Perry R et al (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67:1931–1934PubMedCrossRef
4.
Zurück zum Zitat Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22:1272–1277PubMedCrossRef Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22:1272–1277PubMedCrossRef
5.
Zurück zum Zitat Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G (2009) Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72:1121–1126PubMedCrossRef Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G (2009) Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72:1121–1126PubMedCrossRef
6.
Zurück zum Zitat Adler CH, Caviness JN, Sabbagh MN et al (2010) Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment. Acta Neuropathol 120:827–828PubMedCrossRef Adler CH, Caviness JN, Sabbagh MN et al (2010) Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment. Acta Neuropathol 120:827–828PubMedCrossRef
7.
Zurück zum Zitat Jellinger KA (2010) Neuropathology in Parkinson’s disease with mild cognitive impairment. Acta Neuropathol 120:829–830 (author reply 831)PubMedCrossRef Jellinger KA (2010) Neuropathology in Parkinson’s disease with mild cognitive impairment. Acta Neuropathol 120:829–830 (author reply 831)PubMedCrossRef
8.
Zurück zum Zitat Alves G, Bronnick K, Aarsland D et al (2010) CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson’s disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 81:1080–1086PubMedCrossRef Alves G, Bronnick K, Aarsland D et al (2010) CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson’s disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 81:1080–1086PubMedCrossRef
9.
Zurück zum Zitat Montine TJ, Shi M, Quinn JF et al (2010) CSF Abeta(42) and tau in Parkinson’s disease with cognitive impairment. Mov Disord 25:2682–2685PubMedCrossRef Montine TJ, Shi M, Quinn JF et al (2010) CSF Abeta(42) and tau in Parkinson’s disease with cognitive impairment. Mov Disord 25:2682–2685PubMedCrossRef
10.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
11.
Zurück zum Zitat Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH (2010) A comparison of gray and white matter density in patients with Parkinson’s disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 25:28–34PubMed Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH (2010) A comparison of gray and white matter density in patients with Parkinson’s disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 25:28–34PubMed
12.
Zurück zum Zitat Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH (2010) Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 75:2009–2016PubMedCrossRef Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH (2010) Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 75:2009–2016PubMedCrossRef
13.
Zurück zum Zitat Kim H, Na DL (1999) Normative data on the Korean version of the Boston naming test. J Clin Exp Neuropsychol 21:127–133PubMedCrossRef Kim H, Na DL (1999) Normative data on the Korean version of the Boston naming test. J Clin Exp Neuropsychol 21:127–133PubMedCrossRef
14.
15.
Zurück zum Zitat Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36PubMedCrossRef Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36PubMedCrossRef
16.
Zurück zum Zitat Masliah E, Rockenstein E, Veinbergs I et al (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer’s disease and Parkinson’s disease. Proc Natl Acad Sci USA 98:12245–12250PubMedCrossRef Masliah E, Rockenstein E, Veinbergs I et al (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer’s disease and Parkinson’s disease. Proc Natl Acad Sci USA 98:12245–12250PubMedCrossRef
17.
Zurück zum Zitat Tsigelny IF, Crews L, Desplats P et al (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer’s and Parkinson’s diseases. PLoS One 3:e3135PubMedCrossRef Tsigelny IF, Crews L, Desplats P et al (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer’s and Parkinson’s diseases. PLoS One 3:e3135PubMedCrossRef
18.
Zurück zum Zitat Rowe CC, Ng S, Ackermann U et al (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68:1718–1725PubMedCrossRef Rowe CC, Ng S, Ackermann U et al (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68:1718–1725PubMedCrossRef
19.
Zurück zum Zitat Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH (2011) The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status. Mov Disord 26:289–296PubMedCrossRef Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH (2011) The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status. Mov Disord 26:289–296PubMedCrossRef
20.
Zurück zum Zitat Jicha GA, Schmitt FA, Abner E et al (2010) Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging 31:1805–1813PubMedCrossRef Jicha GA, Schmitt FA, Abner E et al (2010) Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging 31:1805–1813PubMedCrossRef
Metadaten
Titel
The pattern of cortical atrophy in Parkinson’s disease with mild cognitive impairment according to the timing of cognitive dysfunction
verfasst von
Ji E. Lee
Kyoo H. Cho
Myonghwan Kim
Young H. Sohn
Phil Hyu Lee
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 3/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6203-x

Weitere Artikel der Ausgabe 3/2012

Journal of Neurology 3/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.